- Previous Close
0.0355 - Open
0.0355 - Bid 0.0355 x 5270000
- Ask 0.0470 x 5270000
- Day's Range
0.0355 - 0.0355 - 52 Week Range
0.0315 - 0.0860 - Volume
3,000 - Avg. Volume
0 - Market Cap (intraday)
406.798M - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Mar 19, 2024
- Forward Dividend & Yield 0.00 (2.22%)
- Ex-Dividend Date May 23, 2023
- 1y Target Est
--
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.
www.ck-lifesciences.comRecent News: LSI.F
Performance Overview: LSI.F
Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LSI.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LSI.F
Valuation Measures
Market Cap
406.80M
Enterprise Value
1.03B
Trailing P/E
165.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.54
Price/Book (mrq)
0.68
Enterprise Value/Revenue
1.63
Enterprise Value/EBITDA
13.87
Financial Highlights
Profitability and Income Statement
Profit Margin
0.32%
Return on Assets (ttm)
1.24%
Return on Equity (ttm)
0.41%
Revenue (ttm)
5.32B
Net Income Avi to Common (ttm)
17.25M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
676.16M
Total Debt/Equity (mrq)
141.58%
Levered Free Cash Flow (ttm)
57.61M